A CLINICAL-TRIAL OF CONTINUOUS CISPLATIN-FLUOROURACIL INDUCTION CHEMOTHERAPY AND SUPRACRICOID PARTIAL LARYNGECTOMY FOR GLOTTIC CARCINOMA CLASSIFIED AS T2
O. Laccourreye et al., A CLINICAL-TRIAL OF CONTINUOUS CISPLATIN-FLUOROURACIL INDUCTION CHEMOTHERAPY AND SUPRACRICOID PARTIAL LARYNGECTOMY FOR GLOTTIC CARCINOMA CLASSIFIED AS T2, Cancer, 74(10), 1994, pp. 2781-2790
Background. Vertical partial laryngectomy (VPL) and radiation therapy
(RT) are the recommended conventional conservative options for glottic
carcinoma classified as T2. In series presenting more than 100 patien
ts with a minimum 3-year follow-up, however, local recurrence rates we
re reported as 22-43.5%. The authors' experience with a new strategy b
ased on continuous cisplatin-fluorouracil induction chemotherapy (IC)
and supracricoid partial laryngectomy with cricohyoepiglottopexy (CHEF
) is presented. Methods. A retrospective analysis of 67 patients who p
resented with untreated moderately to well differentiated invasive glo
ttic carcinoma classified as T2, managed from 1983 to 1991 with IC and
CHEF, was conducted. Statistical analysis of survival, local control,
nodal control, distant metastasis, and metachronous second primary tu
mor incidence was based on the Kaplan-Meier actuarial method. Univaria
te analysis was performed to analyze the relationships between various
factors and survival, local recurrence, and nodal recurrence. Clinica
l response, histologic response, IC toxicity and postoperative course
were reported. Results. The Kaplan-Meier 5-year survival, local recurr
ence, nodal recurrence, distant metastasis, and metachronous second pr
imary tumor estimate were 92.3%, 5.6%, 1.5%, 1.8%, and 5.6%, respectiv
ely. Overall laryngeal preservation was achieved in 65 patients (97%).
Ultimate local control was achieved in all patients but one. Nodal re
currence was statistically more likely in patients presenting with a l
ocal recurrence. Analysis of the specimens demonstrated complete histo
logic response to IC in 25 (37.3%) patients. A strong statistical rela
tion (P < 0.0001) was noted between complete clinical response after I
C and complete histologic response. Conclusions. The change from the p
revailing treatment modalities of RT and VPL to a new multimodal state
gy (IC + CHEF) did not decrease survival and allowed for an increase i
n laryngeal preservation rate. The high rate (37.3%) of complete histo
logic response suggests that IC deserves further consideration in the
management of patients with glottic carcinoma classified as T2. The fa
vorable results achieved in this series, when compared with historic c
ontrols, should stimulate prospective clinical trials comparing the tw
o surgical procedures (CHEF vs. VFL with or without IC) for resection
of Stage II glottic carcinoma.